Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.2 EUR | -2.78% | +36.81% | -37.31% |
May. 06 | Carmat: progress in ongoing clinical study | CF |
May. 06 | CARMAT Continues to Build on Its Momentum in the EFICAS Study | CI |
Evolution of the average Target Price on CARMAT
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering CARMAT
ODDO BHF |
EPS Revisions
- Stock Market
- Equities
- ALCAR Stock
- Consensus CARMAT